Effect of a combined oral contraceptive on patency of arterial anastomosis in a female rat model

被引:4
作者
Dadaci, Mehmet [1 ]
Oztekin, Can [2 ]
Oztekin, Pelin Seher [3 ]
Sargon, Mustafa Fevzi [4 ]
Ozgur, Figen [5 ]
机构
[1] Necmettin Erbakan Univ, Meram Med Fac, Dept Plast Reconstruct & Aesthet Surg, TR-42080 Meram, Konya, Turkey
[2] Acibadem Ankara Hosp, Dept Plast Reconstruct & Aesthet Surg, Ankara, Turkey
[3] Ankara Numune Training & Res Hosp, Dept Radiol, Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Anat, TR-06100 Ankara, Turkey
[5] Hacettepe Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, TR-06100 Ankara, Turkey
关键词
HORMONAL CONTRACEPTIVES; VENOUS THROMBOEMBOLISM; RISK; ESTROGEN;
D O I
10.1002/micr.22474
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundOral contraceptives, which may lead to thrombotic events, are widely used drugs by women in reproductive age, some of whom might need emergent or elective microsurgical intervention. This study was planned to investigate the effects of combined oral contraceptives (COC) on arterial anastomosis patency in female rat model. MethodsA third generation COC (ethinyl estradiol and desogestrel) was used in this study. A total of 50 female Wistar albino rats were included. The rats were divided into two groups. Experimental group received 0.03 mg ethinyl estradiol/0.15 mg desogestrel with gastric catheter for 20 days before the surgery. Afterward, the femoral arteries of all rats were divided and anastomosed. The patency of the anastomoses were assessed surgically (at 15 min, 7th day) and radiologically with Doppler ultrasonography (at 3rd and 7th days). The samples were examined using light microscopy, scanning electron microscopy (SEM), and transmission electron microscopy (TEM). ResultsThe early patency assessed in the 15th min showed arterial flow in all rats. But at the 7th day 68% of the anastomosis were patent in the COC group while 100% of the anastomosis were patent in the control group as demonstrated surgically and radiologically (P=0.004). Microscopic examination showed an increase in cytoplasmic organelles and activation of endothelial cells in all rats in the experimental group that received COCs. ConclusionThe present study demonstrated the negative effects of the use of COCs on anastomosis patency in rats. (c) 2015 Wiley Periodicals, Inc. Microsurgery 35:553-559, 2015.
引用
收藏
页码:553 / 559
页数:7
相关论文
共 19 条
[1]   Risk of stroke in women exposed to low-dose oral contraceptives - A critical evaluation of the evidence [J].
Chan, WS ;
Ray, J ;
Wai, EK ;
Ginsburg, S ;
Hannah, ME ;
Corey, PN ;
Ginsberg, JS .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (07) :741-747
[2]   Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys [J].
Darroch, Jacqueline E. ;
Singh, Susheela .
LANCET, 2013, 381 (9879) :1756-1762
[3]   Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats [J].
Durand, P ;
Blache, D .
ATHEROSCLEROSIS, 1996, 121 (02) :205-216
[4]   ORAL-CONTRACEPTIVE ESTROGEN AND PROGESTIN POTENCIES AND THE INCIDENCE OF DEEP VENOUS THROMBOEMBOLISM [J].
GERSTMAN, BB ;
PIPER, JM ;
FREIMAN, JP ;
TOMITA, DK ;
KENNEDY, DL ;
FERGUSON, WJ ;
BENNETT, RC .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (04) :931-936
[5]  
GLADSON CL, 1988, THROMB HAEMOSTASIS, V59, P18
[6]   Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model [J].
Ke, HZ ;
Chen, HK ;
Simmons, HA ;
Qi, H ;
Crawford, DT ;
Pirie, CM ;
ChidseyFrink, KL ;
Ma, YF ;
Jee, WSS ;
Thompson, DD .
BONE, 1997, 20 (01) :31-39
[7]   The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational research [J].
Lewis, MA ;
Heinemann, LAJ ;
MacRae, KD ;
Bruppacher, R ;
Spitzer, WO .
CONTRACEPTION, 1996, 54 (01) :5-13
[8]   Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals [J].
Maier, WE ;
Herman, JR .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2001, 34 (01) :53-61
[9]   Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis [J].
Martinelli, I ;
Battaglioli, T ;
Mannucci, PM .
PHARMACOGENETICS, 2003, 13 (10) :589-594
[10]   Hormonal contraceptives and venous thromboembolism: An epidemiological update [J].
Plu-Bureau, Genevieve ;
Maitrot-Mantelet, Lorraine ;
Hugon-Rodin, Justine ;
Canonico, Marianne .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 27 (01) :25-34